chr22-23801197-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000491967.2(SMARCB1):​n.779C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 1,396,810 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0065 ( 12 hom., cov: 32)
Exomes 𝑓: 0.00083 ( 11 hom. )

Consequence

SMARCB1
ENST00000491967.2 non_coding_transcript_exon

Scores

3

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -2.86

Publications

2 publications found
Variant links:
Genes affected
SMARCB1 (HGNC:11103): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1) The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
SMARCB1 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • intellectual disability, autosomal dominant 15
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • rhabdoid tumor predisposition syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • SMARCB1-related schwannomatosis
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
  • familial multiple meningioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • schwannomatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 22-23801197-C-T is Benign according to our data. Variant chr22-23801197-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 133391.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00649 (989/152340) while in subpopulation AFR AF = 0.0221 (920/41578). AF 95% confidence interval is 0.0209. There are 12 homozygotes in GnomAd4. There are 461 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 989 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCB1NM_003073.5 linkc.500+116C>T intron_variant Intron 4 of 8 ENST00000644036.2 NP_003064.2 Q12824-1
SMARCB1NM_001362877.2 linkc.554+62C>T intron_variant Intron 4 of 8 NP_001349806.1
SMARCB1NM_001317946.2 linkc.527+62C>T intron_variant Intron 4 of 8 NP_001304875.1 G5E975Q9H836
SMARCB1NM_001007468.3 linkc.473+116C>T intron_variant Intron 4 of 8 NP_001007469.1 Q12824-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCB1ENST00000644036.2 linkc.500+116C>T intron_variant Intron 4 of 8 NM_003073.5 ENSP00000494049.2 Q12824-1

Frequencies

GnomAD3 genomes
AF:
0.00650
AC:
989
AN:
152222
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0222
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00180
AC:
352
AN:
196096
AF XY:
0.00130
show subpopulations
Gnomad AFR exome
AF:
0.0243
Gnomad AMR exome
AF:
0.00123
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000691
Gnomad FIN exome
AF:
0.0000564
Gnomad NFE exome
AF:
0.000217
Gnomad OTH exome
AF:
0.000773
GnomAD4 exome
AF:
0.000835
AC:
1039
AN:
1244470
Hom.:
11
Cov.:
17
AF XY:
0.000715
AC XY:
448
AN XY:
626770
show subpopulations
African (AFR)
AF:
0.0246
AC:
713
AN:
29022
American (AMR)
AF:
0.00146
AC:
58
AN:
39730
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24406
East Asian (EAS)
AF:
0.0000268
AC:
1
AN:
37368
South Asian (SAS)
AF:
0.000101
AC:
8
AN:
79498
European-Finnish (FIN)
AF:
0.0000584
AC:
3
AN:
51378
Middle Eastern (MID)
AF:
0.00186
AC:
10
AN:
5380
European-Non Finnish (NFE)
AF:
0.000181
AC:
167
AN:
924528
Other (OTH)
AF:
0.00149
AC:
79
AN:
53160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00649
AC:
989
AN:
152340
Hom.:
12
Cov.:
32
AF XY:
0.00619
AC XY:
461
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0221
AC:
920
AN:
41578
American (AMR)
AF:
0.00327
AC:
50
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68036
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
49
98
146
195
244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00966
Hom.:
3
Bravo
AF:
0.00762
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 24, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24728327) -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.068
DANN
Benign
0.54
PhyloP100
-2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35782584; hg19: chr22-24143384; COSMIC: COSV104371126; API